The neuroprotective effect of Dl-3-n-butylphthalide in epileptic rats via inhibiting endoplasmic reticulum stress

被引:3
|
作者
Tian, Shuang [1 ,2 ]
Qu, Zhenzhen [1 ]
Cao, Huifang [3 ]
Niu, Xiaoli [4 ]
Qiao, Qi [1 ]
Zhang, Bing [2 ]
Jia, Lijing [1 ]
Wang, Weiping [1 ,5 ]
机构
[1] Hebei Med Univ, Hosp 2, Dept Neurol, Shijiazhuang, Hebei, Peoples R China
[2] Shijiazhuang Peoples Hosp, Dept Neurol, Shijiazhuang, Hebei, Peoples R China
[3] Hebei Med Univ, Hosp 2, Dept Rehabil, Shijiazhuang, Hebei, Peoples R China
[4] Hebei Gen Hosp, Dept Neurol, Shijiazhuang, Hebei, Peoples R China
[5] Hebei Med Univ, Hosp 2, Dept Neurol, 215 Heping West Rd, Shijiazhuang 050000, Hebei, Peoples R China
关键词
Dl-3-n-Butylphthalide; epilepsy; endoplasmic reticulum stress; apoptosis; neuroprotection; UNFOLDED PROTEIN RESPONSE; APOPTOSIS; INSIGHTS;
D O I
10.5114/fn.2022.123516
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Introduction: The purpose of this study is to investigate whether Dl-3-n-Butylphthalide (NBP) has a neuroprotective effect on pilocarpine-induced epileptic (EP) rats through endoplasmic reticulum stress (ERS)-mediated apoptosis. Material and methods: The Sprague-Dawley rats were divided into four groups: control (CON), EP, EP + NBP60 (NBP 60 mg/kg) and EP + NBP120 (NBP 120 mg/kg) groups. After the successful establishment of the temporal lobe EP model using the lithium-pilocarpine, the rats were given NBP for 28 consecutive days in EP + NBP60 and EP + NBP120 groups. Then, the spontaneous recurrent seizure (SRS) latency, SRS frequency and seizure duration were observed in each group. In order to observe the abnormal discharge of rats, the intracranial electrodes were implanted to monitor the electroencephalogram. Nissl staining was used to observe the damage to the hippocampal CA1 neurons, TUNEL staining was employed to observe hippocampal neuronal apoptosis. Western blot was used to detect the expression of ERS and ERS-mediated apoptotic proteins. Results: NBP60 and NBP120 decreased SRS frequency (all p < 0.05), shortened seizure duration (all p < 0.05), and reduced the abnormal discharge of the brain. Nissl staining and TUNEL staining results show that NBP protected the hippocampal neurons from damage (all p < 0.05) and inhibited hippocampal neuronal apoptosis in EP rats (all p < 0.05). NBP60 and NBP120 could reduce ERS and ERS-mediated apoptotic protein expression in EP rats (all p < 0.05). In addition, the therapeutic effect of NBP on epilepsy in rats is dose-dependent. The SRS frequency of the EP + NBP120 group was lower, and the seizure duration was shorter than in the EP + NBP60 group (all p < 0.05), and there were more neurons in the EP + NBP120 group than in the EP + NBP60 group (p < 0.05). Conclusions: NBP had a significant neuroprotective effect in EP rats. Large doses of NBP are more effective than low doses. The mechanism may be associated with the inhibition of ERS and ERS-mediated apoptosis.
引用
收藏
页码:185 / 195
页数:11
相关论文
共 50 条
  • [31] Dl-3-n-Butylphthalide Exerts Dopaminergic Neuroprotection Through Inhibition of Neuroinflammation
    Chen, Yajing
    Wu, Tingting
    Li, Heng
    Li, Xuan
    Li, Qing
    Zhu, Xiaoying
    Yu, Mei
    Kuo, Sheng-Han
    Huang, Fang
    Wu, Yun-Cheng
    FRONTIERS IN AGING NEUROSCIENCE, 2019, 11
  • [32] Dl-3-n-Butylphthalide (NBP): A Promising Therapeutic Agent for Ischemic Stroke
    Wang, Shan
    Ma, Fei
    Huang, Longjian
    Zhang, Yong
    Peng, Yuchen
    Xing, Changhong
    Feng, Yipu
    Wang, Xiaoliang
    Peng, Ying
    CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS, 2018, 17 (05) : 338 - 347
  • [33] Dl-3-n-butylphthalide pretreatment attenuates renal ischemia/reperfusion injury
    Dong, Yang
    Yin, Jianyong
    Chen, Teng
    Wen, Jiejun
    Zhang, Qunzi
    Li, Xiaomei
    Lin, Wenjun
    Liu, Feng
    Fan, Ying
    Wang, Niansong
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2021, 557 : 166 - 173
  • [34] DL-3-n-Butylphthalide Attenuates Myocardial Hypertrophy by Targeting Gasdermin D and Inhibiting Gasdermin D Mediated Inflammation
    Han, Bingjiang
    Xu, Jiajun
    Shi, Xiaowen
    Zheng, Zhanxiong
    Shi, Fengjie
    Jiang, Fenfen
    Han, Jibo
    FRONTIERS IN PHARMACOLOGY, 2021, 12
  • [35] Dl-3-n-Butylphthalide Reduced Neuroinflammation by Inhibiting Inflammasome in Microglia in Mice after Middle Cerebral Artery Occlusion
    Liu, Mengdi
    Zheng, Haoran
    Liu, Ze
    Guo, Yiyan
    Wang, Shuhong
    Tang, Yaohui
    Tian, Hengli
    Zhang, Zhijun
    Yang, Guoyuan
    LIFE-BASEL, 2022, 12 (08):
  • [36] Dl-3-n-butylphthalide promotes remyelination process in cerebral white matter in rats subjected to ischemic stroke
    Cheng, Xi
    Wang, Huibin
    Liu, Chang
    Zhong, Shanshan
    Niu, Xueli
    Zhang, Xiuchun
    Qi, Ruiqun
    Zhao, Shanshan
    Zhang, Xiaoqian
    Qu, Huiling
    Zhao, Chuansheng
    BRAIN RESEARCH, 2019, 1717 : 167 - 175
  • [37] Dl-3-N-butylphthalide promotes angiogenesis and upregulates sonic hedgehog expression after cerebral ischemia in rats
    Zhou, P.
    Wang, L.
    Qu, M.
    Shen, H.
    Zheng, H.
    Wang, Y.
    Tang, Y.
    Tian, H.
    Zhang, Z.
    Yang, G. Y.
    JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM, 2019, 39 : 138 - 139
  • [38] Dl-3-n-butylphthalide Attenuates Spinal Cord Injury via Regulation of MMPs and Junction Proteins in Mice
    Binbin Zheng
    Yanjun Jin
    Shuang Mi
    Wei Xu
    Xiangdong Yang
    Zhenghua Hong
    Zhangfu Wang
    Neurochemical Research, 2021, 46 : 2297 - 2306
  • [39] Inhibiting of GRASP65 Phosphorylation by DL-3-N-Butylphthalide Protects against Cerebral Ischemia-Reperfusion Injury via ERK Signaling
    Zhu, Bei-lei
    Xie, Chen-long
    Hu, Ning-ning
    Zhu, Xin-bo
    Liu, Chun-feng
    BEHAVIOURAL NEUROLOGY, 2018, 2018
  • [40] Dl-3-N-butylphthalide promotes angiogenesis and upregulates sonic hedgehog expression after cerebral ischemia in rats
    Zhou, Pan-Ting
    Wang, Li-Ping
    Qu, Mei-Jie
    Shen, Hui
    Zheng, Hao-Ran
    Deng, Li-Dong
    Ma, Yuan-Yuan
    Wang, Yu-Yang
    Wang, Yong-Ting
    Tang, Yao-Hui
    Tian, Heng-Li
    Zhang, Zhi-Jun
    Yang, Guo-Yuan
    CNS NEUROSCIENCE & THERAPEUTICS, 2019, 25 (06) : 748 - 758